Artificial Intelligence

Mawson Infrastructure reports a steep Q4 revenue drop but a smaller annual loss, clearing major legal hurdles to focus on its AI and green energy future.

The new iGarden M1 Pro Max, a CES honoree, uses 3D vision to redefine pool cleaning, but it enters a crowded market of increasingly intelligent rivals.

As HUTCHMED prepares to unveil its 2025 financials, investors weigh a complex picture of global drug success, domestic pressures, and pipeline promise.

China's top pig farmer, Muyuan Foods, raises HK$10.7B in a landmark Hong Kong IPO, fueling a high-tech global expansion into Southeast Asia and beyond.

With battery fires on the rise, Wanxiang A123 has unveiled a new semi-solid-state and immersion-cooled system designed to eliminate thermal runaway.

ASUS's new PE1000U packs Intel Core Ultra 2 power into a tiny, fanless chassis, aiming to accelerate AI at the rugged industrial edge.

A new cancer drug using DNA fragments to deliver chemotherapy more safely has been cleared for US trials, offering hope for less toxic treatments.

A new report predicts autonomous AI agents will soon run marketing, transforming brand-consumer relationships and the very role of the CMO. Are you ready?

ACG becomes the first pharma packaging firm in the WEF's elite Lighthouse Network, using AI to slash defects and energy use, setting a new global standard.

With only 20% of Aussie SMEs insured against cyber threats, Cowbell and Zurich launch an AI-powered platform to simplify and expand coverage.

Akeso's innovative dual-action antibody secures its fifth breakthrough nod, offering a lifeline for patients with advanced biliary tract cancer.

Ascentage Pharma's next-gen BTK degrader, APG-3288, receives dual IND clearance, paving the way for clinical trials to fight resistant blood cancers.

Recognized as a Major Player by IDC, South Korea's SK shieldus leverages its AI platform to expand globally and serve businesses of all sizes.

Stunning real-world data shows Iovance's Amtagvi is more effective in earlier melanoma treatment, potentially changing clinical practice and offering new hope.

Early trial data for ABX1100 reveals a novel approach to reducing muscle damage in Pompe disease, offering hope for less burdensome treatment.

With the appointment of Kash Mohammed as President, intelliSPEC signals a major push to unify its platform and lead the AI revolution in industrial asset management.

Tampa Bay Wave's 2026 accelerator welcomes 15 elite startups, signaling the region's growing dominance in the global cybersecurity landscape.

As Amwell prepares its 2025 results, investors watch to see if its strategic pivot to profitability can redefine the future of digital healthcare.

Scrum Alliance has refreshed its mission, pivoting to 'Agile for Anyone' to equip all professionals for a world transformed by AI and automation.

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?